Arisaema

Arisaema: A Comprehensive Reference

1. Identity and Botanical Classification

Arisaema is a large genus of perennial herbaceous plants belonging to the family Araceae (the arum family). The genus comprises approximately 180 perennial herbs widely distributed in the evergreen and deciduous forests. A later Springer-published review places the species count even higher: the genus Arisaema is mainly found in temperate to tropical areas of all continents except South America, Europe, and Australia, and contains more than 250 species.

Among its species, the Asiatic species are often called cobra lilies while Western species are often called jack-in-the-pulpit. The medicinal literature focuses principally on a cluster of East Asian and South Asian species. In Chinese medicine, Arisaema refers to the tubers of Arisaema consanguineum Schott, or other species, including A. erubescens, A. heterophyllum, and A. amurense; the Chinese name is tiannanxing (天南星).

Additional medically studied species include Arisaema flavum, Arisaema tortuosum, Arisaema intermedium, Arisaema jacquemontii, Arisaema murrayi, Arisaema utile, Arisaema leschenaultii, Arisaema yunnanense, Arisaema serratum, Arisaema calcareum, and Arisaema anurans, among others.

In North America, Arisaema triphyllum, also known as jack-in-the-pulpit, Indian turnip, bog onion, and brown dragon, belongs to the family Araceae. However, the North American species are not typically used as dietary supplements or in formal herbal medicine traditions.

1.1 Taxonomy and Synonyms

• Arisaema consanguineum Schott — Chinese name: Tiannanxing (天南星); also called Hoyang-hek in some regional contexts
• Arisaema heterophyllum Blume — also referred to as Tiannanxing; the predominant official species in modern Chinese practice
• Arisaema erubescens (Wall.) Schott — an officially recognized source herb in the Chinese Pharmacopoeia
• Arisaema amurense Maxim. — northeastern Asian species also included in official pharmacopoeial standards
• Arisaema triphyllum — North American jack-in-the-pulpit; toxicologically studied but not used in formal herbal medicine
• Arisaema jacquemontii Blume — Himalayan cobra lily, used in South Asian ethnomedicine
• Arisaema flavum (Forssk.) Schott — found across northwest Himalayan regions of Pakistan and India
• Arisaema tortuosum (Wall.) Schott — whipcord cobra lily, distributed across the Himalayas and China

1.2 Plant Morphology and Geographical Distribution

Wild Arisaema is distributed in the provinces of Yunnan, Sichuan, Xizang, Hubei, Taiwan, and others, and generally grows in shrubs, in valleys, on grass slopes, on riverbanks, and in undergrowth. South Asian species are found across Pakistan, India, and the Himalayan foothills. Arisaema tortuosum is found in the regions of scrub and alpine meadows in the Himalaya, southern India, western China, Myanmar, and Rhododendron forest areas in Baragali, Khyber Pakhtunkhwa, Pakistan.

The primary medicinal part across virtually all traditions is the tuber or rhizome. The tuberous rhizomes are dug in autumn or winter. After the fibrous roots and bark have been removed, the rhizomes are dried in the sun and cut into slices. All species are harvested in October and fumigated with sulfur.

1.3 Official Pharmacopoeial Status

Since 1953, Arisaema has been included in different editions of the Chinese Pharmacopoeia based on its known effects and intense toxicity. To date, three different species from the genus have been included in the Chinese Pharmacopoeia (2020 edition). Only two kinds of processed products are included in the Chinese Pharmacopoeia: Arisaematis Rhizoma Preparatum and Arisaema cum bile.

2. Traditional and Historical Use

2.1 China — The Central Tradition

Arisaema, a traditional Chinese medicine (TCM), was first recorded in Shen Nong's Herbal Classic (神农本草经) under the name 'Huzhang', while it appeared in Medica Gleanings (本草拾遗) under the name 'Tiannanxing'. Arisaematis Rhizoma has more than 2,000 years of history in China as a traditional medicinal plant.

In TCM theory, Arisaema is considered to have bitter, pungent, and warm properties, and is associated with the Lung, Liver, and Spleen meridians. It was found that Arisaematis Rhizoma had the functions of drying dampness and resolving phlegm, dispelling wind and calming nerves, and eliminating swelling and resolving knots. It can be used to treat apoplectic phlegm, mouth and eyes askew, hemiplegia, wind-phlegm vertigo, epilepsy, convulsion, tetanus, scrofula, carbuncle, and fall and fold injury.

Classical TCM prescriptions include specific combinations. For phlegm-damp cough manifested as profuse, dilute and white sputum and stifling sensation in the chest, Arisaema tuber (Tiannanxing) is used with Pinellia tuber (Banxia), Tangerine peel (Chenpi) and Immature bitter orange (Zhishi) in the formula Daotan Tang. For wind-phlegm manifested as dizziness, vertigo, rattling sound in the windpipe, facial paralysis, epilepsy, and convulsions in tetanus, Arisaema tuber is used with Pinellia tuber (Banxia), Gastrodia tuber (Tianma) and Typhonium tuber (Baifuzi).

A distinct bile-processed preparation, known as Dannanxing, plays a specific role. When Arisaema tuber is powdered and mixed with ox bile, it is called Arisaema tuber with bile (Dannanxing). The combination is bitter and cool. It clears heat and resolves phlegm, dispels wind, and stops convulsions. It is used to treat convulsions, windstroke, and epilepsy.

Li Shizhen's Bencao Gangmu (Compendium of Materia Medica, 16th century) engaged with the herb's taxonomy. A study of old illustrations of the herbs has revealed that Li Shizhen had merged or confused the different herbs Pinellia pedatisecta and Arisaema heterophyllum as one. This reflects the close historical botanical and therapeutic relationship between these two genera in Chinese practice.

2.2 South and Central Asia

The herb is traditionally used for the treatment of rheumatoid arthritis, stubborn phlegm, cough, epilepsy, snakebite, tetanus, and other ailments.

Arisaema jacquemontii Blume is a medicinally important plant used for the treatment of different diseases, especially dermatological disorders. The juice extracted from the tubers of this plant applied to the skin is used to cure ringworms and other skin diseases by the Garo and Khasi tribes of Meghalaya (India). The oil obtained by grinding the rhizomes of A. jacquemontii is used to make a paste for massage purposes to recover muscular strength and is also used to cure skin problems including pimples and blisters.

Arisaema flavum is an important medicinal plant found in the northwest Himalayan regions of Pakistan. It is a poisonous plant and is used as a remedy against snake bites and scorpion stings.

Arisaema speciosum (Mart.) in Pakistan is used for flatulence, skin infections, and asthmatic problems.

2.3 Processing for Traditional Use

Like pinellia, Arisaema is toxic in its raw state and is processed to make it suitable for internal use. The processing method is essentially the same as that for pinellia. In ancient times, milk, liquor, ginger juice, licorice water, ash juice, and mint juice were common ingredients used in the processing of Arisaema. In modern research, ginger, alum, and bile are more effective than previously used substances in reducing toxicity and increasing efficiency.

When prescribed internally, it is always used dried, and almost always in conjunction with fresh ginger root. Dried Arisaema root is used internally to treat coughs, tumors, epilepsy, and muscle spasms. Externally, fresh Arisaema root can be applied to the skin to treat skin ulcers and other conditions.

3. Key Chemical Constituents and Active Compounds

Approximately 260 compounds, including flavonoids, alkaloids, saccharides, steroids, fatty acids, amino acids, and volatile oils, have been separated and identified from the genus Arisaema.

3.1 Principal Phytochemical Classes

The comprehensive literature on genus Arisaema indicates the presence of terpenoids, flavonoids, and glycosphingolipids as the principal chemical constituents. Additionally, phytosterols, alkaloids, carboline derivatives, and miscellaneous compounds were documented.

Phytochemical studies have shown that Arisaema is rich in various ingredients, containing polysaccharides, flavonoids, alkaloids, steroids, amino acids, fatty acids, volatile oils, lectins, and other components.

• Flavonoids and C-glycosides: From the ethanol extract of the rhizome of A. erubescens, six compounds were isolated and identified, including schaftoside, isoschaftoside, apigenin-6-C-galactosyl-8-C-arabinoside, apigenin-6-C-arabinosyl-8-C-galactoside, apigenin-6,8-di-C-β-D-glucopyranoside, and apigenin-6,8-di-C-β-D-galactoside.
• Alkaloids: A novel pyrrolidine alkaloid, (2R*,3S*,5S*)-N,2-dimethyl-3-hydroxy-5-(10-phenyldecyl)pyrrolidine, and 17 known compounds were isolated from Arisaema franchetianum Engl. (Araceae) tubers. Carboline derivatives and trigonelline are among the additional alkaloid-class compounds documented in multiple species.
• Steroids and Phytosterols: Stigmasterol is an extensively studied phytosterol recovered from multiple Arisaema species. Stigmasterol represents a typical phytosterol and is widely present in the deodorized distillate of various plants and plant oil refining, with the content accounting for about 22%.
• Triterpenoids: Pentacyclic triterpenoids, including limonoids, have been isolated. In literature, most of the terpenoids are well known for their antitumor, antiviral, and anti-inflammatory activities.
• Lectins: Tuber lectins of Arisaema species are being used for medicinal purposes. A tuber lectin purified from A. jacquemontii has been reported to exhibit potent anti-insect and anti-proliferative activities.
• Polysaccharides, saponins, tannins, coumarins, and oxalates: This plant has some major phytoconstituents which belong to the flavonoids, alkaloids, campesterol, glycosides, terpenes, oxalates, phenols, n-alkanes, tannins, saponins, n-alkanols, sitosterols, stigmasterols, coumarins, lectins, and triterpenoids.

3.2 Established Mechanisms of Action

Several mechanistic pathways have been proposed on the basis of preclinical (in vitro and animal) research:

• Apoptosis induction: The anticancer mechanism of toxic Chinese medicinal herbs mainly exerts a cytotoxic effect by directly killing cancer cells, by inducing apoptosis and differentiation.
• PPARγ-mediated pathway: Peroxisome proliferator-activated receptor gamma (PPARγ) inhibition was investigated to clarify the regulation mechanism of stigmasterol. The results revealed that stigmasterol administration markedly inhibited the viability but promoted lipid deposition of NCI-H1975 cells.
• Lectin-mediated antiproliferative activity: A lectin isolated from Arisaema flavum has exhibited mitogenic and antiproliferative activity against cancer cell lines.
• Renal inflammation and oxidative stress (toxicity pathway): Crude Arisaematis Rhizoma caused renal damage by stimulating inflammation and oxidative stress, as confirmed by the increased production of IL-1β, TNF-α and MDA, and decreased levels of SOD, GSH/GSSH, and GSH-Px.
• Alum/lectin interaction (detoxification): Alum solution can dissolve and degrade the lectin protein on the raphide and destroy the structure of the toxin protein. The content of active lectin protein in Arisaema was decreased after processing with ginger and alum, and the decrease was intimately related to the degradation and deformation of the lectin protein.
• Calcium oxalate raphide mechanism (irritancy): Calcium oxalates are needle-like crystals which, when ingested, may pierce the mouth, throat, and digestive tract as they pass through and cause intense discomfort, producing pain and edema. They also affect conjunctiva and skin on contact.

4. Scientific Evidence by Area of Use

Important prefatory note: A lot of facets of this genus like phytoconstituents identification, mechanistic profile, adverse effects, and clinical studies are still quite limited. The vast majority of the current evidence base consists of in vitro (cell culture) and in vivo (animal) studies. Human clinical trials on Arisaema as an isolated agent are essentially absent from the published English-language literature.

4.1 Anticancer / Antitumor Activity

Evidence level: Preclinical (in vitro and animal models) only.

Biological investigations led to the credentials of antioxidant, anticancer, insecticidal, antimicrobial, anthelmintic, and hepatoprotective activities. However, none of these credentials have yet been translated into registered human clinical trials.

At the cellular level, a cell-line study published in PMC examined the effects of stigmasterol from A. heterophyllum on lung adenocarcinoma: in a study using Swiss albino mice, the antitumor effect of stigmasterol on Ehrlich ascites carcinoma was examined, in which stigmasterol was intraperitoneally injected at doses of 5 and 10 mg/kg respectively. As compared with the blank control, the inhibition rates of stigmasterol on tumor cells were 49.92 and 60.11%, respectively. This is an animal model result and does not demonstrate clinical efficacy in humans.

The water extract of A. heterophyllum has been shown to have a specific inhibitory effect on cancer cells. Compound Sansheng injection containing A. heterophyllum produces an obvious inhibitory effect on lung cancer and Ehrlich ascites carcinoma in mice. Again, these are animal-model data.

In vitro cytotoxic studies on A. jacquemontii showed that according to SRB cytotoxic effects, A. jacquemontii is highly active against DU-145 and HL-60 cancer cell lines. The n-hexane extract showed higher cytotoxicity against both cancer cell lines while other extracts did not show remarkable activity.

A 2022 study isolated two bioactive compounds from Arisaema flavum rhizome extract and evaluated: two bioactive compounds were isolated from the Arisaema flavum rhizome extract, and their anticancer activities against breast cancer cell lines were assessed. Full details of compound identification and outcomes in these cell lines were reported in the PMC-indexed publication but results are in vitro only.

Several plant species are described as promising candidates for the treatment of cancer, parasitic diseases, and microbial infection complications. Though, a lot of facets of this genus like phytoconstituents identification, mechanistic profile, adverse effects, and clinical studies are still quite limited.

4.2 Neurological / Anticonvulsant and Sedative Effects

Evidence level: Animal studies and limited historical clinical application within TCM formulas; no standalone human RCTs.

Traditional use of Arisaema for epilepsy, convulsions, and wind-stroke (apoplexy) is among the most longstanding applications in Chinese medicine. Rhizoma Arisaematis is a traditional Chinese medicine commonly used in the treatment of convulsions, inflammation, and cancer.

One animal study in ICR mice investigated whether traditional processing altered pharmacological profiles: the study investigated the effects exerted by untreated crude Rhizoma Arisaematis and different preparations treated with alumen in combination with ginger juice (Zhinanxing) or bile juice (Dannanxing). Both Zhinanxing and Dannanxing water extracts exerted significantly increased sedative effects, as indicated by the inhibitory effects on ambulatory distances, jumps, vertical-plane entries, and prolonged pentobarbital-induced sleeping time. The extracts also exerted significantly increased analgesic effects in mice compared to the unprocessed crude preparation.

A large number of Arisaema species have been reported as anticonvulsants in preclinical settings, but no systematic review of human clinical data on this application is currently available in the peer-reviewed English literature.

4.3 Anti-Inflammatory Activity

Evidence level: In vitro and animal studies; no human clinical data identified.

Isolated compounds from Arisaema exhibit wide-ranging pharmacological activities such as antitumor activity, analgesic and sedative activity, antioxidant activity, and anti-inflammatory activity. Rheumatoid arthritis is among the historically documented indications: the herb is traditionally used for the treatment of rheumatoid arthritis, stubborn phlegm, cough, epilepsy, snakebite, tetanus, and other ailments. However, as with most areas of Arisaema research, no controlled human trials have been published demonstrating efficacy for inflammatory conditions.

4.4 Antimicrobial Activity

Evidence level: In vitro studies; no human clinical trials.

Several in vitro studies across different species have demonstrated antibacterial and antifungal properties. A study of Arisaema flavum crude extract published in a PMC-indexed journal found that it was active against all bacterial strains except Staphylococcus aureus. Maximum zone of inhibition (13.9 mm) was observed against Pseudomonas picketti. An average zone of 10–11 mm was observed against Micrococcus luteus, Bacillus subtilis, and Salmonella Setubal.

A study on Arisaema tortuosum published in the Pakistan Journal of Pharmaceutical Sciences screened methanolic extracts and fractions against eight bacterial pathogens and six fungal pathogens. Significant antibacterial activity was observed for Pseudomonas aeruginosa (27.16 ± 0.60) followed by Bacillus cereus (18.55 ± 0.69) for the crude methanolic extract. Non-significant antifungal activity was observed for the plant extracts.

An in silico computational docking study examined phytoconstituents of Arisaema as potential inhibitors against human respiratory syncytial virus (RSV): approximately 60 phytochemical entities were evaluated on the docking behavior of human RSV receptor (PDB: 4UCC). Notably, rutin (glide score: −8.49), schaftoside (glide score: −8.18), and apigenin-6,8-di-C-β-D-galactoside (glide score: −7.29) resulted in hopeful natural lead hits with an ideal range of kinetic descriptor values. This is purely computational evidence and has not been tested in cell culture or animals for antiviral efficacy.

4.5 Antioxidant Activity

Evidence level: In vitro only.

Significant amounts of phenolic contents were determined in ethanol and methanol extracts of A. jacquemontii (210.3 ± 3.05 and 193.2 ± 3.15 μg GAE/mg, respectively). Maximum flavonoid content was determined in the methanol extract (22.4 ± 4.04 μg QE/mg). Secondary metabolites (phenolic acids, flavonoids, anthocyanidins, and tannins) isolated from these plants have shown remarkable antioxidant and immunomodulatory activities in in vitro assays.

4.6 Anthelmintic (Anti-Parasitic) Activity

Evidence level: Animal/in vitro studies only.

The rhizomes or tubers of A. calcareum, A. serratum, A. asperatum, A. heterophyllum, and A. amurense are documented as having analgesic, antitumor, and pesticidal potential. An essential oil study on A. franchetianum and A. lobatum published in the Journal of Ethnopharmacology assessed anthelmintic activity against Haemonchus contortus, a parasitic nematode relevant to livestock medicine.

4.7 Hepatoprotective Activity

Evidence level: Preliminary preclinical findings; no human clinical data.

Biological investigations led to the credentials of antioxidant, anticancer, insecticidal, antimicrobial, anthelmintic, and hepatoprotective activities. Several plant species are promising candidates for the treatment of cancer, parasitic diseases, and microbial infection complications. However, hepatoprotective evidence in humans is not established.

5. Body Systems and Health Areas Associated with Arisaema

Based on the totality of traditional and scientific literature, the following health areas are associated with Arisaema:

• Respiratory system: Treatment of phlegm-producing coughs, bronchial conditions, and excess mucous production has been the hallmark of tiannanxing in TCM for over two millennia.
• Neurological system: Epilepsy, convulsions, tetanus, wind-stroke (apoplexy), and vertigo — particularly when characterized by the TCM pattern of "wind-phlegm."
• Musculoskeletal system: Rheumatoid arthritis, soft tissue injuries, hemiplegia, facial paralysis, and muscular disorders, used both internally and topically.
• Dermatological: Topical application for skin ulcers, ringworm, skin infections, and inflammatory skin conditions in several South Asian folk traditions.
• Oncology (investigational): In vitro and animal models for lung, gastric, and breast cancer, and leukemia cell lines; no human clinical evidence.
• Infectious disease (investigational): In vitro antibacterial, antifungal, antileishmanial, and computational antiviral studies; no human clinical evidence.
• Renal system (toxicological concern): Crude preparations are associated with nephrotoxicity; processed forms mitigate this risk in animal models.

Phytochemical studies have shown that Arisaema is rich in polysaccharides, flavonoids, alkaloids, steroids, amino acids, fatty acids, volatile oils, lectins, and other components. Researchers have revealed remarkable antitumor, analgesic/sedative, anticonvulsant, cardioprotective, antioxidative, apophlegmatic, anti-inflammatory, antibacterial, and insecticidal effects.

6. Dosage Forms and Reported Dosages

Dosage information for Arisaema is primarily drawn from TCM clinical practice standards and a small number of animal studies. No verified human pharmacokinetic dose-escalation studies have been published in the accessible English-language literature. The following are dosages as stated in cited sources only:

• Internal decoction (TCM practice): The typical dosage of Arisaema is between 4–9 grams per day, taken with boiling water as a decoction, depending on the condition being treated.
• Arisaema tuber (standard TCM reference): Dosage: 5–10 g.
• Bile-processed Arisaema (Dannanxing): The recommended dosage is 2–5 g.
• Animal study (nephrotoxicity research): Extracts of crude and processed Arisaematis Rhizoma products at 1 g/kg were intragastrically administered to rats once daily for four consecutive weeks.
• Animal study (stigmasterol anticancer): Stigmasterol was intraperitoneally injected into mice with ascites cancer at doses of 5 and 10 mg/kg respectively.

Processed forms are consistently distinguished from raw forms across all sources. This herb is contraindicated during pregnancy. In general, the raw herb is not used for internal use.

7. Safety Considerations and Toxicology

7.1 Calcium Oxalate Crystal Toxicity

The toxic effects of Arisaema are due to calcium oxalate crystals. The toxicity ranges from minor oral cavity edema to lethal airway obstruction. Calcium oxalates are needle-like crystals which, when ingested, may pierce the mouth, throat, and digestive tract as they pass through and cause intense discomfort, producing pain and edema. They also affect conjunctiva and skin on contact. Edema is primarily due to direct trauma from the needle-like crystals but bradykinins also play some role in edema formation. Majority of cases are among children younger than five years.

Most cases are self-limiting, and morbidity and mortality is rare. But a small dose of oxalate toxin is enough to cause intense sensations of burning in the mouth and throat, swelling, hypersalivation, and choking. The airway edema and obstruction can possibly be lethal.

7.2 Lectin and Protein-Mediated Irritant Toxicity

It has been reported that calcium oxalate crystals, lectins, and Pinellia ternata agglutinin and trypsin inhibitor-like proteins are the main contributors to Arisaematis Rhizoma irritant toxicity. A previous study has proven that oral administration of Arisaematis Rhizoma ethanol extract worsened renal function with a significant increase in blood urea nitrogen. Ge et al. found that Arisaematis Rhizoma could induce light vacuolization of glomerular matrix and edema of renal tubular epithelial cells.

7.3 Nephrotoxicity

A dedicated metabolomics study on A. erubescens in a rat model directly investigated the mechanism of renal toxicity: crude Arisaematis Rhizoma caused renal damage by stimulating inflammation and oxidative stress, as confirmed by the increased production of IL-1β, TNF-α, and MDA, and decreased levels of SOD, GSH/GSSH, and GSH-Px. Processing with ginger juice, alumen, and bile juice alleviated the damage to kidney. Metabolomics results showed that a total of 35 potential biomarkers enriched in amino acid metabolism, glycerophospholipid metabolism, and fatty acid-related pathways were deduced to be responsible for the nephrotoxicity of Arisaematis Rhizoma and the toxicity-reducing effect of processing.

7.4 Processing as a Detoxification Strategy

Raw Arisaema is described as having strong irritant toxicity. Therefore, the processed products of Arisaema are frequently used in the clinic. Two standardized processing methods are recognized:

• Zhinanxing (alum + ginger processing): Crude Arisaematis Rhizoma is soaked in several changes of water until foam is visualized. After soaking with alum for one day, it is decocted with sliced ginger and alum to yield the processed form.
• Dannanxing (bile fermentation): There is an alternate processing method in which pig bile is added to the Arisaema to produce bile-processed Arisaema (dannanxing; dan = bile), which has a dark green color.

Poisonous components have been identified and the underlying mechanisms of toxicity are under scientific investigation. However, determining the safety of Arisaema is a tough task due to the diversity of the genus. The distinct chemical components and effects caused by differences among the species, growing environment, and harvest time also make safety assessments challenging.

7.5 Pregnancy Contraindication

This herb is contraindicated during pregnancy. In general, the raw herb is not used for internal use. This is a consistent finding across TCM materia medica sources.

7.6 Drug Interactions

No controlled human pharmacokinetic drug interaction studies have been published. Available caution signals are derived from pharmacological characterization studies. Pharmacological studies showed antitumor, analgesic/sedative, anticonvulsant, cardioprotective, antioxidant, expectorant, anti-inflammatory, antibacterial, and insecticidal activities, suggesting theoretical overlaps with pharmaceutical agents affecting the central nervous system, cardiovascular system, and platelet function. These theoretical interactions have not been studied in controlled human research.

8. Evidence Gaps and Research Limitations

Plants in the genus Arisaema are described as valuable resources with therapeutic potential for a broad spectrum of ailments. Based on the limited literature, comprehensive and systematic review of current knowledge of the genus has been summarized for the first time. However, there have been insufficient studies on the active ingredients and germplasm and insufficient in-depth mechanistic studies.

Arisaema genus has claimed various traditional bioactivities, but scientific assessments are quite limited. Specifically, the following gaps are documented in the reviewed literature:

• No registered, peer-reviewed human randomized controlled trials (RCTs) evaluating any isolated Arisaema extract or compound as a monotherapy for any clinical condition have been identified.
• The anticancer, anticonvulsant, and anti-inflammatory activities remain at the preclinical stage; translation to human evidence is not yet demonstrated.
• Chemical compounds from plants in the genus Arisaema have not been comprehensively reported. In the past few years, most phytochemistry research has focused only on investigations of official species while ignoring other traditional species.
• Species-to-species variation in chemical composition significantly complicates generalization of findings across the genus.
• Processing reduces Arisaematis Rhizoma nephrotoxicity through multiple metabolic pathways, but the exact pharmacokinetic data for human doses and bioavailability of key active compounds remain poorly characterized.

References

• Genus Arisaema: A Review of Traditional Importance, Chemistry and Biological Activities — PubMed (Combinatorial Chemistry & High Throughput Screening, 2020)
• Genus Arisaema: A Review of Traditional Importance, Chemistry and Biological Activities — Bentham Science / EurekaSelect
• A Comprehensive Review of Research Progress on the Genus Arisaema: Botany, Uses, Phytochemistry, Pharmacology, Toxicity and Pharmacokinetics — PubMed (Journal of Ethnopharmacology, 2021)
• A Comprehensive Review of Research Progress on the Genus Arisaema — ScienceDirect (Journal of Ethnopharmacology, 2021)
• Arisaema — Overview, ScienceDirect Topics
• Botanical, Traditional Use, Phytochemical, and Toxicological of Arisaematis Rhizoma — Evidence-Based Complementary and Alternative Medicine, Wiley, 2021
• Traditional Uses, Phytochemistry, Pharmacology and Toxicity of Arisaema (Araceae): A Review — Bulletin of the National Research Centre, Springer, 2021
• Poisoning due to Arisaema triphyllum Ingestion — Indian Journal of Critical Care Medicine, PMC/NIH, 2019
• Poisoning due to Arisaema triphyllum Ingestion — PubMed
• Insight into Nephrotoxicity and Processing Mechanism of Arisaema erubescens by Metabolomics and Network Analysis — PMC / Drug Design, Development and Therapy, 2023
• Insight into Nephrotoxicity and Processing Mechanism of Arisaema erubescens — PubMed
• Arisaema heterophyllum Blume Monomer Stigmasterol Targets PPARγ and Inhibits Lung Adenocarcinoma Cells — PMC / NIH, 2022
• Phytochemical, In-Vitro Biological and Chemo-Preventive Profiling of Arisaema jacquemontii Blume Tuber Extracts — PMC / BMC Complementary Medicine and Therapies, 2019
• Phytochemical, In-Vitro Biological and Chemo-Preventive Profiling of Arisaema jacquemontii Blume Tuber Extracts — PubMed
• Antibacterial Activity of Some Selected Medicinal Plants of Pakistan — PMC / BMC Complementary and Alternative Medicine, 2011
• Antibacterial, Antifungal, Phytotoxic, Antioxidant and Hemagglutination Activities of Arisaema tortuosum — PubMed / Pakistan Journal of Pharmaceutical Sciences, 2016
• Computational Breakthrough of Natural Lead Hits from the Genus of Arisaema against Human Respiratory Syncytial Virus — PMC, 2018
• Isolation, Characterization and Anticancer Activity of Two Bioactive Compounds from Arisaema flavum — PMC / NIH, 2022
• Chemical Constituents of Arisaema franchetianum Tubers — PubMed (Journal of Asian Natural Products Research, 2013)
• Pinellia, Arisaema, Acorus and Typhonium — Institute for Traditional Medicine (ITM Online); Subhuti Dharmananda, PhD
• Evidence for Improved Neuropharmacological Efficacy and Decreased Neurotoxicity with Traditional Processing of Rhizoma Arisaematis — American Journal of Chinese Medicine, World Scientific, 2011
• Arisaema Tuber (Tiannanxing) — ePharmacognosy
• Arisaema (Tian Nan Xing) — Acupuncture Today Herb and Botanical Reference